Manage inventory costs, navigate NHS reimbursement delays, and invest in clinical services that set your pharmacy apart.



2,400+ businesses fundedNo upfront fees • Free quote in minutesTwo banks told me to come back next year. These guys had the money in my account by Thursday.
Nobody ran a hard search, nobody played games. The offer they showed me is the offer I got.
Bought a second van right before our busy season. It paid for itself in two months.


We fund the business on its revenue — not your possessions.

Repayment follows your actual sales — strong months pay more, slow months ease up.

Most owners see offers the same day and money within ~24 hours of signing.
Independent pharmacies face a financial squeeze from every direction: NHS reimbursement under the Drug Tariff has been held flat for years while drug acquisition costs continue to rise, Category M clawbacks and margin-survey adjustments create unpredictable revenue reductions months after prescriptions are dispensed, and the cost of maintaining adequate inventory ties up hundreds of thousands in capital. Despite these pressures, independent pharmacies remain essential community healthcare providers with loyal patient bases and opportunities to grow through clinical services.
Granton Hale Capital understands the unique economics of independent community pharmacy. We evaluate your business based on prescription item volume, average reimbursement per item, NHS-versus-private mix, and clinical service revenue — not just the bottom-line numbers that don't tell the full story of a pharmacy's financial health. We know that a pharmacy dispensing 8,000+ items per month with strong community relationships has durable revenue even when NHS margins are tight. A soft search means checking eligibility won't affect your credit score.
Our pharmacy clients use funding to finance inventory (especially high-cost specials and specialist medicines), refit dispensing areas, invest in NHS Advanced Services (Pharmacy First, flu and travel vaccinations, the New Medicine Service, blood-pressure checks), and expand into new locations or service lines such as compounding. We structure repayment around your NHS reimbursement cycle so cash flow remains manageable.
Funding under the Drug Tariff has been squeezed for over a decade while acquisition costs rise. Category M clawbacks and margin-survey adjustments — applied months after dispensing — create unpredictable revenue reductions that are nearly impossible to plan around.
Maintaining adequate pharmaceutical stock requires £150K–£750K+ in capital. Specials and specialist medicines can cost £8K–£40K per item, and wholesaler payment terms of 7 to 30 days leave little float between purchasing and NHS reimbursement, which typically arrives around two months in arrears.
Boots, Superdrug, supermarket pharmacies, and distance-selling players like Pharmacy2U leverage scale and online dispensing. Independent pharmacies must differentiate through service quality, clinical programmes, and community relationships — all of which require investment.
GPhC inspection standards, NHS terms of service, Responsible Pharmacist requirements, and accreditation for Advanced and Enhanced Services create ongoing administrative and technology expenses.
Bridge NHS reimbursement delays, manage Category M clawbacks, and cover operational expenses during tight cash-flow periods.
Revolving credit for managing variable inventory purchasing costs — draw funds when placing wholesaler orders and repay as NHS reimbursements arrive.
Structured financing for branch refits, new location fit-outs, and investment in specialist dispensing or compounding accreditation.
Finance pharmacy automation systems (ScriptPro, Parata, robotic dispensers), point-of-care testing equipment, and dispensing technology upgrades.



Fund the purchase of high-cost specials and specialist medicines and maintain adequate stock levels without depleting operating capital.
Launch Pharmacy First consultations, flu and travel vaccination services, the New Medicine Service, and blood-pressure and hypertension case-finding that generate higher-margin revenue.
Install robotic dispensing systems, automated tablet counters, and workflow management software to increase efficiency and reduce dispensing error rates.
Fund lease deposits, fit-out, opening stock, and staffing costs for opening a second pharmacy in an underserved area.
Real businesses, real outcomes. Names and details changed for privacy — the numbers are typical of funded files.
Yes. We're familiar with the financial pressures independent pharmacies face from flat Drug Tariff funding, Category M clawbacks, and margin-survey adjustments. We factor these dynamics into our underwriting and structure repayment terms that account for the timing gaps between dispensing and NHS reimbursement collection.
Yes. Specialist medicine inventory financing is one of the most impactful ways we help pharmacies. A single specials item can cost £8K–£40K in acquisition cost with reimbursement arriving weeks later. We provide working capital and revolving credit facilities specifically suited for managing these high-cost inventory needs.
Yes. We fund acquisitions of existing pharmacies, including the purchase price, stock transfer, and transition working capital. We evaluate the target pharmacy's item volume, NHS-versus-private mix, and patient retention potential as part of the underwriting process.
We fund the investments needed for specialist and distance-selling pharmacy accreditation, including technology upgrades, compliance systems, staff training, and the working capital needed to build specialist stock before accreditation is complete and contracts are in place.